Compare TRTX & TLRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TRTX | TLRY |
|---|---|---|
| Founded | 2014 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Medicinal Chemicals and Botanical Products |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 708.3M | 1.7B |
| IPO Year | 2017 | 2018 |
| Metric | TRTX | TLRY |
|---|---|---|
| Price | $9.16 | $11.86 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 3 |
| Target Price | $10.75 | ★ $150.00 |
| AVG Volume (30 Days) | 516.7K | ★ 9.5M |
| Earning Date | 10-28-2025 | 01-09-2026 |
| Dividend Yield | ★ 10.48% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.65 | N/A |
| Revenue | $138,590,000.00 | ★ $830,766,000.00 |
| Revenue This Year | N/A | $7.28 |
| Revenue Next Year | $8.19 | $4.51 |
| P/E Ratio | $14.14 | ★ N/A |
| Revenue Growth | ★ 4.13 | 2.31 |
| 52 Week Low | $6.47 | $3.51 |
| 52 Week High | $9.85 | $23.20 |
| Indicator | TRTX | TLRY |
|---|---|---|
| Relative Strength Index (RSI) | 59.61 | 91.51 |
| Support Level | $9.01 | $7.10 |
| Resistance Level | $9.17 | $8.64 |
| Average True Range (ATR) | 0.14 | 0.62 |
| MACD | 0.01 | 0.78 |
| Stochastic Oscillator | 87.00 | 96.31 |
TPG RE Finance Trust Inc is a commercial real estate finance company. It originates, acquires, and manages commercial mortgage loans and other commercial real estate-related debt instruments consisting of first mortgage loans and senior participation interests in first mortgage loans secured by institutional-quality properties in primary and select secondary markets in the United States. The company's objective is to provide attractive risk-adjusted returns to its stockholders over time through cash distributions and capital appreciation. It focuses on directly originating and selectively acquiring floating rate first mortgage loans that are secured by high quality commercial real estate properties undergoing some form of transition and value creation.
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure comes mostly from alcohol.